1. Seo JW. Obesity in children and adolescents. Korean J Pediatr. 2009; 52:1311–1320.
Article
2. Weiss R, Kaufman FR. Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care. 2008; 31:Suppl 2. S310–S316.
3. Hong YM. Metabolic syndrome in children and adolescents. Korean J Pediatr. 2009; 52:737–744.
Article
4. Chueh HW, Cho GR, Yoo JH. Clinical significance of acanthosis nigricans in children and adolescents with obesity induced metabolic complications. Korean J Pediatr. 2007; 50:987–994.
Article
5. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, et al. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med. 1976; 294:739–745.
Article
6. Dietz WH. Overweight in childhood and adolescence. N Engl J Med. 2004; 350:855–857.
Article
7. Slyper AH, Kashmer L, Huang WM, Re'em Y. Acanthosis nigricans, vitamin D, and insulin resistance in obese children and adolescents. J Pediatr Endocrinol Metab. 2014; 27:1107–1111.
Article
8. Patidar PP, Ramachandra P, Philip R, Saran S, Agarwal P, Gutch M, et al. Correlation of acanthosis nigricans with insulin resistance, anthropometric, and other metabolic parameters in diabetic Indians. Indian J Endocrinol Metab. 2012; 16:S436–S437.
Article
10. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005; 115:e500–e503.
Article
11. Burke JP, Hale DE, Hazuda HP, Stern MP. A quantitative scale of acanthosis nigricans. Diabetes Care. 1999; 22:1655–1659.
Article
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37:Suppl 1. S81–S90.
13. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002; 106:3143–3421.
14. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007; 56:901–916.
Article
15. Hermanns-Lê T, Scheen A, Piérard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004; 5:199–203.
16. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L. Acanthosis nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab. 1991; 73:590–595.
Article
17. Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994; 31:1–19.
Article
18. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993; 44:121–131.
Article
19. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, et al. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr. 1989; 114:963–967.
Article
20. Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM. Acanthosis nigricans among native Americans: an indicator of high diabetes risk. Am J Public Health. 1994; 84:1839–1842.
Article
21. Stuart CA, Peters EJ, Prince MJ, Richards G, Cavallo A, Meyer WJ 3rd. Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess. Metabolism. 1986; 35:197–205.
Article
22. Venkatswami S, Anandam S. Acanthosis nigricans: a flag for insulin resistance. J Endocrinol Metab Diabetes South Afr. 2014; 19:68–74.
Article
23. Noviarti D, Rini EA, Oenzil F. Association of resistin level with acanthosis nigricans in obese adolescents. Paediatr Indones. 2016; 56:32–36.
Article
24. Kong AS, Williams RL, Rhyne R, Urias-Sandoval V, Cardinali G, Weller NF, et al. Acanthosis nigricans: high prevalence and association with diabetes in a practice-based research network consortium--a PRImary care Multi-Ethnic network (PRIME Net) study. J Am Board Fam Med. 2010; 23:476–485.
Article
25. Yamazaki H, Ito S, Yoshida H. Acanthosis nigricans is a reliable cutaneous marker of insulin resistance in obese Japanese children. Pediatr Int. 2003; 45:701–705.
Article